Skip to main content
CELU
NASDAQ Life Sciences

Major Shareholder's Potential Stake Reduced to 15.8% as Rights Expire

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.758
Mkt Cap
$21.941M
52W Low
$0.667
52W High
$4.35
52W Position info
14% above low
Off High info
83% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

CELU is trading near its 52-week low of $0.667 (14% above the low) on light trading volume (0.2× avg).

Summary

A major shareholder's potential beneficial ownership in Celularity Inc. has been reduced to 15.8% after rights to acquire additional shares expired, clarifying their current maximum stake.


Key Events · Ownership and Investor Activity · CELU

  • Beneficial Ownership Updated

    The Philip & Daniele Barach Family Trust now beneficially owns 5,414,686 shares, representing 15.8% of Celularity Inc.'s Class A Common Stock.

  • Potential Stake Reduced

    The trust's right to acquire an additional 2,043,979 shares through convertible notes and warrants expired on June 19, 2026, reducing their maximum potential beneficial ownership from 20.1% to 15.8%.

  • Warrants Became Exercisable

    Warrants to purchase 3,707,457 shares at an exercise price of $2.00 per share, issued on December 19, 2025, became exercisable on June 19, 2026.


Analysis · CELU · Life Sciences

This amendment to a Schedule 13D clarifies the beneficial ownership of the Philip & Daniele Barach Family Trust in Celularity Inc. Their potential maximum stake has been reduced from 20.1% to 15.8% because their right to acquire additional convertible notes and warrants expired on June 19, 2026. While the trust remains a significant shareholder, this update indicates they are not increasing their investment beyond the current level, which could be viewed negatively given the company's recent delisting notice.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CELU was trading at $0.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.9M. The 52-week trading range was $0.67 to $4.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CELU - Latest Insights

CELU
Nov 10, 2026, 4:30 PM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.720
Real-time Price: $0.6191 info
Change: -$0.1009 (-14%) info
Market Cap: $20.09M info
CELU
Oct 28, 2026, 5:52 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.6191 info
Change: -$0.3609 (-37%) info
Market Cap: $20.09M info
CELU
Oct 20, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.6191 info
Change: -$0.6409 (-51%) info
Market Cap: $20.09M info
CELU
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $0.6191 info
Change: -$0.9959 (-62%) info
Market Cap: $20.09M info
CELU
Sep 29, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $0.6191 info
Change: -$0.7709 (-55%) info
Market Cap: $20.09M info